Related Experiment Video

Updated: Mar 28, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.5K

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas

Michalis V Karamouzis1, Georgia Dalagiorgou1, Urania Georgopoulou2

  • 1Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Oncotarget
|December 31, 2015
PubMed

Insights

Resistance to HER-2 therapies in breast cancer is linked to HER-3. This study reveals HER-3 dimerization patterns and shows their potential to predict treatment efficacy in specific patient groups.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Membrane receptor tyrosine kinases play a key role in breast carcinogenesis.
  • Epidermal growth factor receptor (EGFR) and HER-2 targeted therapies have shown clinical success.
  • Intrinsic or acquired resistance to HER-2 therapies, often due to HER-3, limits treatment efficacy.

Purpose of the Study:

  • To investigate the dimerization patterns of HER-3 in breast cancer.
  • To understand the context-dependent dimer formation of HER-3 with other HER family members.
  • To explore the predictive value of HER protein dimerization patterns for novel HER-3 targeting agents.

Main Methods:

  • Utilized proximity ligation assay (PLA) to evaluate HER-3 dimerization.
  • Analyzed context-dependent dimer formation between HER-3 and other HER family members.
  • Validated the dimerization model in human paraffin-embedded breast cancer tissues.

Main Results:

  • Demonstrated specific dimerization patterns of HER-3.
  • Highlighted the importance of context-dependent dimer formation involving HER-3.
  • Showed that HER protein dimerization patterns can predict the efficacy of novel HER-3 targeting agents in certain breast cancer subgroups.
  • Reproduced findings in human breast cancer tissues.

Conclusions:

  • HER-3 dimerization patterns are crucial in breast cancer progression and therapy resistance.
  • The dimerization status of HER protein family members can serve as a biomarker for predicting response to HER-3 targeted therapies.
  • This approach offers a potential strategy for personalized medicine in breast cancer treatment.
Keywords:
ErbBHER-3breast cancerdimerization patternproximity ligation assay

More Related Videos

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.9K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K